Exclusive

Publication

Byline

NATIONAL INSTITUTES OF HEALTH ISSUES NOTICE: CENTER FOR SCIENTIFIC REVIEW; NOTICE OF CLOSED MEETINGS

WASHINGTON, April 15 -- National Institutes of Health has issued a notice called: Center for Scientific Review; Notice of Closed Meetings. The notice was published in the Federal Register on April 15... Read More


NATIONAL INSTITUTES OF HEALTH ISSUES NOTICE: CENTER FOR SCIENTIFIC REVIEW; NOTICE OF CLOSED MEETINGS

WASHINGTON, April 15 -- National Institutes of Health has issued a notice called: Center for Scientific Review; Notice of Closed Meetings. The notice was published in the Federal Register on April 15... Read More


DEPARTMENT OF HEALTH AND HUMAN SERVICES ISSUES NOTICE: ADVISORY COUNCIL ON ALZHEIMER'S RESEARCH, CARE, AND SERVICES; MEETING

WASHINGTON, April 15 -- Department Of Health And Human Services has issued a notice called: Advisory Council on Alzheimer's Research, Care, and Services; Meeting. The notice was published in the Fede... Read More


DEPARTMENT OF HEALTH AND HUMAN SERVICES ISSUES NOTICE: HHS OMH CALL FOR NOMINATIONS FOR CENTER FOR INDIGENOUS INNOVATION AND HEALTH

WASHINGTON, April 15 -- Department Of Health And Human Services has issued a notice called: HHS OMH Call for Nominations for Center for Indigenous Innovation and Health. The notice was published in t... Read More


FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: SAFETY ASSESSMENT OF GENOME EDITING IN HUMAN GENE THERAPY PRODUCTS USING NEXT-GENERATION SEQUENCING; DRAFT GUIDANCE FOR INDUSTRY; AVAILABILITY

WASHINGTON, April 15 -- Food and Drug Administration has issued a notice called: Safety Assessment of Genome Editing in Human Gene Therapy Products Using Next-Generation Sequencing; Draft Guidance for... Read More


FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: FINANCIAL TRANSPARENCY AND EFFICIENCY OF THE PRESCRIPTION DRUG USER FEE ACT, BIOSIMILAR USER FEE ACT, AND GENERIC DRUG USER FEE AMENDMENTS; PUBLIC MEETING; REQUEST FOR COMMENTS

WASHINGTON, April 15 -- Food and Drug Administration has issued a notice called: Financial Transparency and Efficiency of the Prescription Drug User Fee Act, Biosimilar User Fee Act, and Generic Drug ... Read More


FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: INCREASING ACCESS TO NONPRESCRIPTION DRUGS; PUBLIC MEETING; REQUEST FOR COMMENTS

WASHINGTON, April 15 -- Food and Drug Administration has issued a notice called: Increasing Access to Nonprescription Drugs; Public Meeting; Request for Comments. The notice was published in the Fede... Read More


ADMINISTRATION FOR CHILDREN AND FAMILIES ISSUES NOTICE: TRIBAL CONSULTATION MEETING

WASHINGTON, April 15 -- Administration for Children and Families has issued a notice called: Tribal Consultation Meeting. The notice was published in the Federal Register on April 15 by Roshelle M. B... Read More


FEDERAL TRADE COMMISSION ISSUES NOTICE: GRANTING OF REQUESTS FOR EARLY TERMINATION OF THE WAITING PERIOD UNDER THE PREMERGER NOTIFICATION RULES

WASHINGTON, April 15 -- Federal Trade Commission has issued a notice called: Granting of Requests for Early Termination of the Waiting Period Under the Premerger Notification Rules. The notice was pu... Read More


FEDERAL TRADE COMMISSION ISSUES NOTICE: TRUHEIGHT; ANALYSIS OF PROPOSED CONSENT ORDER TO AID PUBLIC COMMENT

WASHINGTON, April 15 -- Federal Trade Commission has issued a notice called: TruHeight; Analysis of Proposed Consent Order To Aid Public Comment. The notice was published in the Federal Register on A... Read More